CVRx CVRX
NASDAQ CVRX
$2.83 -0.10 (-3.41%)
At close: Sep 9, 2026 · 4:00 PM EDT

CVRx (CVRX) Cash from Financing Activities (2020 - 2026)

CVRx (CVRX) posted Cash from Financing Activities of $1.2 million for Q2 2026, down 86.25% on a QoQ basis from $8.9 million in Q1 2026, and up 211.48% year-over-year from $392000.0 in Q2 2025.

Analysis

CVRx (CVRX) Cash from Financing Activities (2020 - 2026) Analysis & Trends

CVRx has reported Cash from Financing Activities for 7 years, with the latest figure at $1.2 million in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities rose 211.48% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $10.6 million, a 83.42% decrease from a year earlier, with the FY2025 full-year figure at $10.5 million, down 81.17% from the prior year.
  • Cash from Financing Activities was $1.2 million for Q2 2026 at CVRx, down from $8.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $40.2 million in Q3 2024, with the low at $7000.0 in Q3 2022.
  • Average Cash from Financing Activities over 5 years is $6.0 million, with a median of $847000.0 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities slumped 99.99% in 2022, then soared 15666.67% in 2023.
  • Over 5 years, Cash from Financing Activities stood at $7.1 million in 2022, then jumped by 118.91% to $15.6 million in 2023, then decreased by 11.21% to $13.8 million in 2024, then sank by 97.04% to $410000.0 in 2025, then jumped by 197.8% to $1.2 million in 2026.
  • The last three Cash from Financing Activities figures came in at $1.2 million (Q2 2026), $8.9 million (Q1 2026), and $410000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -287.90 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -343.00 Mn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -300,000.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -510.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -607.30 Mn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -213.50 Mn
10 CVRx 81.26 Mn 16.67 Mn 13.72 Mn 1.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.22 Mn
Mar 31, 2026 8.88 Mn
Dec 31, 2025 410,000.00
Sep 30, 2025 103,000.00
Jun 30, 2025 392,000.00
Mar 31, 2025 9.62 Mn
Dec 31, 2024 13.83 Mn
Sep 30, 2024 40.20 Mn
Jun 30, 2024 472,000.00
Mar 31, 2024 1.36 Mn
Dec 31, 2023 15.58 Mn
Sep 30, 2023 363,000.00
Jun 30, 2023 473,000.00
Mar 31, 2023 7.57 Mn
Dec 31, 2022 7.12 Mn
Sep 30, 2022 7,000.00
Jun 30, 2022 321,000.00
Mar 31, 2022 48,000.00
Dec 31, 2021 -21.29 Mn
Sep 30, 2021 133.17 Mn